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Low cholesterol concentrations and cholesterol-lowering therapies have been suggested to be 
associated with increased suicidality. This article examined the association of cholesterol, 
triglycerides, and body-mass index (BMI) with suicidal ideation and suicide attempts. Findings are 
based on a nationally representative community sample of n = 4,181 subjects (18–65 years) examined 
with a standardized diagnostic interview (CIDI) for (DSM-IV) mental disorders. Controlling for age 
and gender the study revealed a moderate positive association between cholesterol, triglycerides, BMI, 
and suicide attempts in subjects with depressive symptoms during the past 12 months (n = 1,205). The 
results of this study are compatible with two recent epidemiological cohort studies showing a positive 
association between cholesterol and completed suicide.  
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A meta-analysis of selected cholesterol-lowering trials revealed an unanticipated association 
between trial-reduced serum cholesterol concentrations and increased mortality from suicide, 
accidents, trauma, and violence (Muldoon, Manuck, Matthews et al., 1990). Based on these 
findings it has been speculated that cholesterol-lowering therapies may cause or worsen 
depressive symptoms and increase the risk of suicide. However, this meta-analysis has to be 
regarded as inconclusive due to several methodological limitations (review: Brunner, 
Parhofer, Schwandt et al., 2002). A recently published meta-analysis of cholesterol-lowering 
therapies (Muldoon, Manuck, Mendelsohn et al., 2001) including more than 70,000 subjects 
showed no increase of mortality from suicide, accidents, and violence. Statins significantly 
reduce cardiovascular morbidity and mortality (LaRosa, He, & Vupputuri, 1999) without 
increasing mortality from suicide or trauma (Muldoon, Manuck, Mendelsohn et al., 2001).  
 
Evidence for associations of cholesterol and suicidality has also been reported in a series of 
studies in patients with various mental disorders revealing lower total cholesterol 
concentrations in suicide attempters (Golier, Marzuk, Leon et al., 1995; Kim, Lee, Kim et al., 
2002; Kunugi, Takei, Aoki et al., 1997; Papassotiropoulos, Hawellek, Frahnert et al., 1999). 
However, these studies are based on small samples and lack control for confounding variables 
such as depression-related malnutrition and weight-loss, age, gender, dietary habits, alcohol 
consumption, physical activity, and medication effects (review: Brunner, Parhofer, Schwandt 
et al., 2002).  
 
Epidemiological studies in the community, which are usually less vulnerable towards 
confounding factors typical for clinical studies, focused exclusively on completed suicide. 
The results of these studies are controversial. Some studies reported an association between 
lower cholesterol and completed suicide (Partonen, Haukka, Virtamo et al., 1999; Zureik, 
Courbon & Ducimetière, 1996). Another study, however, failed to find such an association 
(Vartiainen, Puska, Pekkanen et al., 1994). Two studies reported a positive association 
between cholesterol and suicide (Iribarren, Reed, Wergowske et al., 1995; Tanskanen, 
Vartiainen, Tuomilehto et al., 2000). No data from general population samples are available 
on the relationship between suicide attempts and suicidal ideation and parameters of 
cholesterol and lipid metabolism.  
 
A further shortcoming of epidemiological studies reporting associations of cholesterol with 
unfavorable health outcomes is that they focused almost exclusively on highly selective 
cohorts of subjects at risk for cardiovascular mortality and morbidity possibly including 
selection bias. Avoiding this potential limitation, the present study examines whether positive 
associations of major depressive episode (MDE), suicide attempts, and suicidal ideation can 
be established with parameters of cholesterol and lipid metabolism in an unselected nationally 
representative community sample of n = 4,181 subjects in the community (German National 





German National Health Interview and Examination Survey (GHS) and its Mental 
Health Supplement (GHS-MHS)  
 
The GHS is a nationwide epidemiological study of both somatic and mental health in 
Germany in a representative adult sample in the community (for detailed description see 
Jacobi, Wittchen, Müller et al., 2002). In brief, it consists of the social and somatic core 
survey (GHS-CS) and the Mental Health Supplement (GHS-MHS). Out of the core survey 
participants (n = 7,124, response rate 61.4%), a subsample was additionally interviewed for 
mental disorders. Respondents of the core survey older than 65 years were excluded because 
the psychometric properties of the CIDI, the interview used in the study, have not yet been 
satisfactorily established for use in older populations (Knäuper & Wittchen, 1994). The 
conditional response rate of the GHS-MHS was 87.6%, resulting in a total of 4,181 
respondents who completed the mental health assessment. In order to adjust the net sample to 
German age, sex and community distribution, data were weighted for age, sex, and region 
corresponding to the national administrative statistics of December 1997. The presented 
weighted results can be regarded as representative for the German noninstutionalized 
population from 18 to 65 years of age (mean age: 42 years) with sufficient language skills to 
follow the interviews.  
 
Assessment of Somatic Diseases and Laboratory Parameters  
 
Diagnoses of somatic disorders were assigned on a composite approach including self-report 
measures, a standardized clinical interview by the medical doctor, and laboratory measures. 
Fasting blood samples were drawn on the day of the standardized medical interview (for 
detailed description see Thierfelder, Seher, & Thefeld, 1998). The following parameters were 
considered for the subsequent analyses: total serum cholesterol, HDL cholesterol, 
triglycerides, BMI, age, and sex.  
 
Psychopathological Assessments  
 
Psychopathological assessments were based on a standardized diagnostic interview according 
to DSM-IV criteria (DIA-X/M-CIDI, Wittchen & Pfister, 1997), administered by trained 
clinical interviewers. Diagnoses were computed using the CIDI/DSM-IV algorithm. 
Suicidality was assessed with the series of CIDI suicidality questions that were presented as 
part of the depression section. These questions comprise a series of six questions summarized 
in the footnote of Table 1. It should be noted that all the suicidality items were only asked to 
respondents who had acknowledged at least one of the core depression items. Thus, detailed 
results for the suicidality items were available for 1,205 individuals (26% of the total sample). 
In the text we present the prevalence of each of the suicidality items for the total sample (n = 
4,181), those without major depressive episode (MDE, n = 3,789) as well as subjects with 
MDE (n = 392, 9.4%).  
 
Statistical Analysis  
 
Findings were adjusted for age and sex in all analyses to control for potential confounding by 
these factors. To account for the weighting scheme as well as the stratified sampling design 
by screening status (Jacobi, Wittchen, Müller et al., 2002), statistical inference (standard 
errors, confidence intervals, and p-values) was based on the Huber-White sandwich estimator 
of variance (Royall, 1986) using the Stata software package, release 7.0 (StataCorp, 2001). 
The associations of suicide attempts, suicidal ideation with BMI, triglycerides, and cholesterol 
were based on odds ratios estimated from logistic regression. For the association analyses, the 
covariates were standardized (mean = 0, standard deviation [SD] = 1). Here, odds ratios 
indicate the increase of the odds for suicidality by increase of the covariates by one SD. 
Furthermore, comparisons of low (below the 25th percentile), normal (25th–75th percentile) 





12-Month Prevalance of Suicidal Ideation and Suicide Attempts  
 
Table 1 shows the 12-month prevalence of suicidal ideation and suicide attempts in the total 
sample (n = 4,181) and among subjects with (n = 392, 9.4%) and without (n = 3,789) MDE 
during the past 12 months. Of the general population, 11.7% reported having had a period 
where most of the time they were „thinking a lot about death.“ More specific suicidal ideation 
items were considerably less frequent with prevalences ranging from 3.8 („feeling like 
wanting to die“) to 1.2 („planning to commit suicide“). The prevalence of attempted suicide 
during the past 12 months was 0.4 in the total sample.  
 
Splitting the total sample (n = 4,181) into those subjects with (n = 392, 9.4%) and without (n 
= 3,789) a major depressive episode (MDE) during the past 12 months revealed that most of 
the prevalence in the total sample was due to subjects with MDE. Among the 392 subjects 
with MDE, 63% reported at least 2 weeks where they were „thinking a lot about death,“ 31% 
reported a period of 2 weeks where they were „feeling like wanting to die,“ 23% were 
thinking about committing suicide, and 11% were planning to commit suicide. The self-
reported prevalence for attempted suicide was 3.4% in subjects with MDE. The presence of 
MDE was associated with a considerably increased risk to report at least one suicidal item 
(odds ratios ranging from 21.8–33.6). It should be noted, however, that suicidality items were 
only assessed in those subjects who had reported at least one core depression item during the 
past 12 months (n = 1,205).  
 
In order to exclude the effect of comorbidity with psychoactive substance use disorder we 
analysed the association between a 12-month diagnosis of MDE and the 12-month diagnoses 
of nicotine dependence, alcohol abuse or dependence, and any illicit drug use disorder (abuse 
or dependence) among n = 1,205 cases with depressive symptoms in the past 12 months. No 
association between MDE and psychoactive substance use disorder in this subsample was 
found. Although suicidal ideation as well as suicide attempts tended to be more frequent 
among those with substance use diagnoses, the only significant associations (after adjusting 
for sex and age) were found between illicit drug abuse/dependence and „planning to commit 
suicide“ (OR = 13.41, 95% CI = 2.08–86.42) and between illicit drug abuse/dependence, and 
„thinking about committing suicide“ (OR = 7.50, 95% CI = 1.17–48.23).  
 
Association between Cholesterol, Triglycerides, BMI, and Suicidality  
 
Logistic regression analysis (Table 2) revealed positive associations of total cholesterol and 
triglycerides with some measures of suicidality („thinking a lot about death“ and „attempted 
suicide“) in subjects with depressive symptoms during the past 12 months (n = 1,205). It is 
noteworthy that despite the low rate for attempted suicide, the association reached statistical 
significance, whereas other items of suicidal ideation („feeling like wanting to die,“ „thinking 
about committing suicide,“ „planning to commit suicide“) did not. Furthermore, BMI was 
positively associated with attempted suicide.  
 
To assess whether our findings could be explained by substance use disorders we repeated the 
analyses in Table 2 by also adjusting for 12 months nicotine dependence, alcohol abuse or 
dependence, and illicit drug abuse or dependence (the latter had to be omitted for the item 
„thinking a lot about death“ because of empty cells). The point estimates of odds ratios 
remained almost equal (data not shown) although the p-values for the associations between 
„triglycerides“ and „thinking a lot about death“ (OR = 1.30, 0.996–1.69), and between „total 
cholesterol“ and „suicide attempts“ (OR = 1.97, 0.98–3.59) moved from barely under the 0.05 
threshold to barely over the 0.05 threshold.  
 
The covariates total cholesterol, triglycerides, and BMI were then split by the 25th and the 
75th percentile and the three groups were compared after adjustment for age and gender 
effects (Table 3). Table 3 shows that subjects with depressive symptoms (n = 1,205) above 
the 75th percentile had a more than fourfold increased odds for attempted suicide compared to 





The aim of this study was to investigate the association between suicidality (suicidal ideation 
and suicide attempts), major depressive episode (MDE), and parameters of cholesterol and 
lipid metabolism in a community sample. This is, to our knowledge, the first epidemiological 
study in a representative community sample to examine whether cholesterol concentrations 
are related to increased suicidal behavior. The strengths of the study are: the sample size, 
detailed psychopathological data, and detailed self-report information about suicidal ideation 
and behavior.  
 
The 12-month prevalence of MDE was 9.4% in this nationally representative sample of 
subjects aged 18–65 years. The 12-month prevalence of attempted suicide was 0.4% in the 
total sample (n = 4,181), but it is noteworthy that indicators of suicidal ideation were much 
more frequent. The proportion of all indicators of suicidality among those subjects with MDE 
was as expected considerably higher with rates of attempted suicide of 3.4%. The presence of 
MDE was associated with a considerably increased risk for all suicidality items with odds 
ratios ranging from 21.8–33.6. These findings are well in accordance with previous studies, 
both for depression (Haarasilta, Marttunen, Kaprio et al., 2001; Lindeman, Hamalainen, 
Isometsä et al., 2000) as well as suicidal ideation (Weissman, Bland, Canino et al., 1999). The 
well known increased odds ratio of suicidal ideation with the presence of major depression is 
in line with previous studies (Dyck, Bland, Newman et al., 1988; Wunderlich, Bronisch, & 
Wittchen, 1998). The findings of our study cannot be explained by comorbidity of 
psychoactive substance use disorder. No association between MDE in the last 12 months and 
psychoactive use disorder (12 months diagnoses of nicotine dependence, alcohol abuse or 
dependence, any illicit drug abuse or dependence) was found in our sample.  
 
The key finding of this study is that total cholesterol and triglycerides showed a positive 
association with attempted suicide and „thinking a lot about death“ in subjects with depressive 
symptoms during the past 12 months versus subjects with major depression without suicide 
attempts. In contrast to previous studies however, low cholesterol concentrations (<5.5 
mmol/l) had a diminished OR for attempted suicide as compared to normal cholesterol 
concentrations, and the BMI was positively associated with attempted suicide. These findings 
are in contrast to some clinical studies in psychiatric patients (review: Brunner, Parhofer, 
Schwandt et al., 2002) as well as some previous epidemiological findings (Partonen, Haukka, 
Virtamo et al., 1999; Zureik, Courbon, & Ducimetière, 1996). Although suicidal ideation and 
suicde attempts tended to be more frequent in our sample among those subjects with 
substance use diagnoses, the only significant associations (after adjusting for sex and age) 
were found between illicit drug abuse/dependence and „planning to commit suicide“ and 
between illicit drug abuse/dependence and „thinking about committing suicide.“ It is difficult 
to explain this divergence of findings, however, design issues seem to primarily account for 
these differences: (1) Previous epidemiological findings refer to cohort studies of 
cardiovascular morbidity and mortality, focussing exclusively on completed suicide. Thus, 
these studies related cholesterol measurements to the rare event of subsequent completed 
suicide occurring years or even decades later and did not assess suicidal ideation or attempted 
suicide. (2) Further, results of the available five studies differ considerably. Two studies 
reporting lower cholesterol in suicide victims only included data for men (Partonen, Haukka, 
Virtamo et al., 1999; Zureik, Courbon, & Ducimetière, 1996). In a cohort of 10,898 men and 
11,534 women, no association between cholesterol and completed suicide was found 
(Vartiainen, Puska, Pekkanen et al., 1994). Iribarren, Reed, Wergowske et al. (1995) reported 
a positive association between cholesterol and risk of suicide in a sample of 7,309 men (24 
suicides after 23 years of follow-up). The relative risk of suicide associated with an increment 
of 0.98 mmol/l in serum cholesterol was 1.46 in their study. In a population of 37,635 
persons, Tanskanen and colleagues (2000) found that serum cholesterol was positively related 
to the risk of violent suicide. Among subjects whose total serum cholesterol was in the highest 
category (>8.0 mmol/l), the adjusted relative risk of violent suicide was more than twofold 
compared with the lowest category (<5.0 mmol/l).  
 
The results of the present study reveal—when splitting the covariates total cholesterol, 
triglycerides, and BMI by the 25th and the 75th percentile and after adjustment for age and 
gender effects— that those subjects with depressive symptoms above the 75th percentile had a 
more than fourfold increased odds for attempted suicide as compared to those below the 25th 
percentile. Subjects with high cholesterol concentrations (>6.42 mmol/l) showed an OR for 
attempted suicide of 4.5 as compared to low cholesterol concentrations (<5.5 mmol/l). These 
findings regarding attempted suicide are consistent with the two epidemiological studies 
reporting a positive association between cholesterol and completed suicide (Iribarren, Reed, 
Wergowske et al., 1995; Tanskanen, Vartiainen, Tuomilehto et al., 2000). However, some 
clinical studies in psychiatric patients with different diagnoses found lower cholesterol 
concentrations in suicide attempters (Golier, Marzuk, Leon et al., 1995; Kim, Lee, Kim et al., 
2002; Kunugi, Takei, Aoki et al., 1997; Muldoon, Manuck, Matthews et al., 1990, 
Papassotiropoulos, Hawellek, Frahnert et al., 1999). The reasons behind this association are 
not clear. Several possible confounders have to be discussed (Brunner, Parhofer, Schwandt et 
al., 2002).  
 
The majority of clinical studies in psychiatric patients and epidemiological studies only 
measured total cholesterol. The results of the present study show that the findings are not 
specific for cholesterol since both high triglycerides and BMI were also positively associated 
with attempted suicide. These findings are in line with the hypothesis that cholesterol may be 
of secondary physiological relevance and that for example polyunsatured fatty acids may be a 
critical confounding factor in the association between cholesterol and suicide (review: 
Brunner, Parhofer, Schwandt et al., 2002). We speculate that a considerable amount of 
patients with higher BMI, triglycerides, and cholesterol may have maladaptive nutritional 
behaviors (such as binge eating). An association between binge eating and suicide attempts 
and suicidal ideation has been described in the literature (Favaro & Santonastaso, 1997; 
Viesselman & Roig, 1985). An alternative explanation could be a higher proportion of 
atypical depression with hyperphagia and weight gain. Another hypothesis would be that 
patients with overweight have more somatic comorbidity which leads to reduced quality of 
life. Some exploratory analysis in the present data set seemed to suggest some preliminary 
evidence for this assumption (data available on request). A limitation of the present study is 
that we cannot exclude possible confounding by antidepressant medication. It is described in 
the literature that mirtazapine increases total cholesterol concentrations and body weight in 
healthy subjects (Nicholas, Ford, Esposito et al., 2003). However, since only a few of the 
subjects in the community studies were on any antidepressant medication during the 





In conclusion, a positive, but moderate association between total cholesterol, triglycerides, 
BMI, and suicide attempts was found in subjects with depressive symptoms in the past 12 
months. The results of this study are compatible with two recent epidemiological cohort 
studies showing a positive association between cholesterol and completed suicide (Iribarren, 
Reed, Wergowske et al., 1995; Tanskanen, Vartiainen, Tuomilehto et al., 2000). Our study 
does not reveal any support for the for the hypothesis that cholesterol-lowering therapies or 
naturally occurring low cholesterol concentrations are associated with increased risk of 
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